KARAKTERISTIK PASIEN COVID-19 DENGAN SINDROM KORONER AKUT DI RSUP DR. M. DJAMIL PADANG

Hana Yulia Rahmi Harahap; Rita Hamdani; Novita Ariani; Arina Widya Murni; Mefri Yanni

Authors

Hana Yulia Rahmi Harahap Universitas Andalas
Rita Hamdani Universitas Andalas
Novita Ariani Universitas Andalas
Arina Widya Murni Universitas Andalas
Mefri Yanni Universitas Andalas

Keywords:

COVID-19, Karakteristik, SKA

Abstract

Pasien terinfeksi coronavirus disease 2019 (COVID-19) memiliki peningkatan risiko terjadinya sindrom koroner akut. Penelitian ini bertujuan untuk mengetahui kejadian dan karakteristik klinis pasien yang dirawat dengan infeksi COVID-19 disertai Sindrom Koroner Akut (SKA) di RSUP Dr. M. Djamil Padang.Penelitian deskriptif retrospektif ini dilakukan di Instalasi Rekam Medis dan Instalasi Rawat Inap RSUP. Dr. M. Djamil Padang dengan mengambil kasus SKA terkonfirmasi COVID-19 dari tahun 2020-2021. Penelitian ini dilakukan dengan teknik total sampling pada 60 orang. Penelitian ini diolah secara komputerisasi dalam bentuk tabel distribusi frekuensi. Hasil penelitian ini adalah 29 orang (48.3%) mengalami infark miokard akut dengan elevasi segmen ST (IMA-EST), 21 orang (34.9%) berusia 55-64 tahun, dan 44 orang (73.3%) berjenis kelamin laki-laki. Faktor risiko terbanyak adalah hipertensi dan riwayat merokok sebanyak 36 orang (60%), serta 49 orang (81.7%) mengalami nyeri dada. Berdasarkan hasil laboratorium, didapatkan kenaikan rata-rata leukosit, neutrofil, troponin, D-dimer, dan marker inflamasi. Penemuan angiografi terbanyak adalah CAD 1 VD sebanyak 12 orang (36.4%). Kesimpulan penelitian ini adalah sebagian besar pasien COVID-19 disertai SKA merupakan kelompok usia 55-64 tahun, berjenis kelamin laki-laki, memiliki komorbid hipertensi dan riwayat merokok, memiliki manifestasi nyeri dada, mengalami peningkatan marker inflamasi, serta adanya single vessel disease pada angiografi koroner

Downloads

Download data is not yet available.

References

Ge H, Wang X, Yuan X, Xiao G, Wang C, Deng T, et al. The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis. 2020 Jun;39(6):1011–9.

COVID-19 WRP. Peta Sebaran [Internet]. covid19.go.id. [cited 2021 Jun 25]. Available from: https://covid19.go.id/peta-sebaran

Esposito L, Cancro FP, Silverio A, Di Maio M, Iannece P, Damato A, et al. COVID-19 and acute coronary syndromes: from pathophysiology to clinical perspectives. Horowitz JD, editor. Oxidative Medicine and Cellular Longevity. 2021 Aug 30;2021:1–13.

Shorikova’ ’Dina V., Shorikov’ ’Eugene I. COVID-19 and acute coronary syndrome: emphasis on ACS without atherothrombosis. Vol. 21.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061.

Kumar A, Cannon CP. Acute coronary syndromes: diagnosis and management, part I. Mayo Clin Proc. 2009 Oct;84(10):917–38.

O’Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, de Lemos JA, et al. 2013 ACCF/AHA Guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation. 2013 Jan 29;127(4):529–55.

Stroobandt R, Barold SS, Sinnaeve AF. ECG from basics to essentials: step by step. Chichester, West Sussex, UK ; Hoboken, NJ: John Wiley & Sons, Inc; 2015.

Kang Y, Chen T, Mui D, Ferrari V, Jagasia D, Scherrer-Crosbie M, et al. Cardiovascular manifestations and treatment considerations in COVID-19. Heart. 2020 Aug;106(15):1132–41.

Tajbakhsh A, Gheibi Hayat SM, Taghizadeh H, Akbari A, inabadi M, Savardashtaki A, et al. COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up. Expert Review of Anti-infective Therapy. 2021 Mar 4;19(3):345–57.

Kite TA, Ludman PF, Gale CP, Wu J, Caixeta A, Mansourati J, et al. International prospective registry of acute coronary syndromes in patients with COVID-19. Journal of the American College of Cardiology. 2021 May;77(20):2466–76.

Rashid M, Wu J, Timmis A, Curzen N, Clarke S, Zaman A, et al. Outcomes of COVID‐19‐positive acute coronary syndrome patients: A multisource electronic healthcare records study from England. J Intern Med. 2021 Jul;290(1):88–100.

Choudry FA, Hamshere SM, Rathod KS, Akhtar MM, Archbold RA, Guttmann OP, et al. High thrombus burden in patients with COVID-19 presenting with ST-segment elevation myocardial infarction. Journal of the American College of Cardiology. 2020 Sep;76(10):1168–76.

Matsushita K, Hess S, Marchandot B, Sato C, Kim NT, Weiss A, et al. Clinical features of patients with acute coronary syndrome during the COVID-19 pandemic. J Thromb Thrombolysis. 2021 Jul;52(1):95–104.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054–62.

Biswas M, Rahaman S, Biswas TK, Haque Z, Ibrahim B. Association of sex, age, and comorbidities with mortality in COVID-19 patients: a systematic review and meta-analysis. Intervirology. 2021;64(1):36–47.

Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Sex, Age, Cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland. Circulation. 1999 Mar 9;99(9):1165–72.

Mauvais-Jarvis F, Klein SL, Levin ER. Estradiol, progesterone, immunomodulation, and COVID-19 outcomes. Endocrinology. 2020 Sep 1;161(9):127.

Guan W jie, Liang W hua, Zhao Y, Liang H rui, Chen Z sheng, Li Y min, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020 May;55(5):2000547.

Guzik TJ, Mohiddin SA, Dimarco A, Patel V, Savvatis K, Marelli-Berg FM, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovascular Research. 2020 Aug 1;116(10):1666–87.

Rashid M, Wu J, Timmis A, Curzen N, Clarke S, Zaman A, et al. Outcomes of COVID‐19‐positive acute coronary syndrome patients: A multisource electronic healthcare records study from England. J Intern Med. 2021 Jul;290(1):88–100.

Hamadeh A, Aldujeli A, Briedis K, Tecson KM, Sanz-Sánchez J, Al dujeili M, et al. Characteristics and outcomes in patients presenting with COVID-19 and ST-segment elevation myocardial infarction. The American Journal of Cardiology. 2020 Sep;131:1–6.

Franck C, Filion KB, Eisenberg MJ. Smoking cessation in patients with acute coronary syndrome. The American Journal of Cardiology. 2018 May;121(9):1105–11.

Samidurai A, Das A. Cardiovascular complications associated with COVID-19 and potential therapeutic strategies. IJMS. 2020 Sep 16;21(18):6790.

Tajbakhsh A, Gheibi Hayat SM, Taghizadeh H, Akbari A, inabadi M, Savardashtaki A, et al. COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up. Expert Review of Anti-infective Therapy. 2021 Mar 4;19(3):345–57.

Bangalore S, Sharma A, Slotwiner A, Yatskar L, Harari R, Shah B, et al. ST-segment elevation in patients with Covid-19 - A Case Series. N Engl J Med. 2020 Jun 18;382(25):2478–80.